202 related articles for article (PubMed ID: 8270867)
41. Regulation of epithelial proliferation by TGF-beta.
Moses HL; Yang EY; Pietenpol JA
Ciba Found Symp; 1991; 157():66-74; discussion 75-80. PubMed ID: 2070684
[TBL] [Abstract][Full Text] [Related]
42. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.
Hasbold J; Klaus GG
Eur J Immunol; 1990 Aug; 20(8):1685-90. PubMed ID: 2209683
[TBL] [Abstract][Full Text] [Related]
43. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas.
Brown DM; Phipps RP
J Immunol; 1996 Aug; 157(4):1359-70. PubMed ID: 8759715
[TBL] [Abstract][Full Text] [Related]
44. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.
Poe JC; Minard-Colin V; Kountikov EI; Haas KM; Tedder TF
J Immunol; 2012 Sep; 189(5):2318-25. PubMed ID: 22826319
[TBL] [Abstract][Full Text] [Related]
45. c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells.
Gururajan M; Chui R; Karuppannan AK; Ke J; Jennings CD; Bondada S
Blood; 2005 Aug; 106(4):1382-91. PubMed ID: 15890690
[TBL] [Abstract][Full Text] [Related]
46. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
47. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition.
Haggerty HG; Monroe JG
Cell Immunol; 1994 Mar; 154(1):166-80. PubMed ID: 8118885
[TBL] [Abstract][Full Text] [Related]
48. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
49. A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death.
Kuss AW; Knödel M; Berberich-Siebelt F; Lindemann D; Schimpl A; Berberich I
Eur J Immunol; 1999 Oct; 29(10):3077-88. PubMed ID: 10540318
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
Watson PH; Pon RT; Shiu RP
Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
[TBL] [Abstract][Full Text] [Related]
51. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells.
Kimura S; Maekawa T; Hirakawa K; Murakami A; Abe T
Cancer Res; 1995 Mar; 55(6):1379-84. PubMed ID: 7882339
[TBL] [Abstract][Full Text] [Related]
52. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
[TBL] [Abstract][Full Text] [Related]
53. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth.
Usa T; Tsukazaki T; Namba H; Ohtsuru A; Kimura H; Villadolid MC; Nagataki S; Yamashita S
Endocrinology; 1994 Oct; 135(4):1378-84. PubMed ID: 7925100
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
[TBL] [Abstract][Full Text] [Related]
55. c-myc promotes survival of WEHI 231 B lymphoma cells from apoptosis.
Wu M; Yang W; Bellas RE; Schauer SL; FitzGerald MJ; Lee H; Sonenshein GE
Curr Top Microbiol Immunol; 1997; 224():91-101. PubMed ID: 9308232
[No Abstract] [Full Text] [Related]
56. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
57. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts.
Cutrona G; Ulivi M; Fais F; Roncella S; Ferrarini M
J Exp Med; 1995 Feb; 181(2):699-711. PubMed ID: 7836923
[TBL] [Abstract][Full Text] [Related]
58. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
[TBL] [Abstract][Full Text] [Related]
59. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
60. STAT3 regulates the growth and immunoglobulin production of BCL(1) B cell lymphoma through control of cell cycle progression.
Karras JG; McKay RA; Lu T; Pych J; Frank DA; Rothstein TL; Monia BP
Cell Immunol; 2000 Jun; 202(2):124-35. PubMed ID: 10896772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
